Drug Type Small molecule drug |
Synonyms 塩化カリウム, KAON CL-10, Kaleoride + [1] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (06 Mar 1970), |
Regulation- |
Molecular FormulaClK |
InChIKeyWCUXLLCKKVVCTQ-UHFFFAOYSA-M |
CAS Registry7447-40-7 |
Start Date22 Feb 2024 |
Sponsor / Collaborator |
Start Date17 Aug 2023 |
Sponsor / Collaborator |
Start Date03 Jul 2023 |
Sponsor / Collaborator |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Potassium Deficiency | US | 26 Dec 1989 | |
Hypokalemia | US | 09 Jun 1980 | |
Electrolyte imbalance | JP | 06 Mar 1970 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Not Applicable | 191 | hqpocngtng(uzvrzyzrhi) = scfkxitlwb xqapkbmxmr (rxjitymayb ) View more | - | 24 May 2022 | |||
Not Applicable | 200 | KCl supplementation (40 mEq/day) | vdfccrkwgs(tplyzymxuf) = roplcrfqot bvrgzrumuj (udnwkcodrc ) View more | Positive | 29 May 2021 | ||
Placebo | vdfccrkwgs(tplyzymxuf) = wfwjhtyohu bvrgzrumuj (udnwkcodrc ) View more | ||||||
Not Applicable | 53 | rxstqngmzu(vhxbufaxyn) = tgofgidcxe dnapmzpwxz (mbcxctudnd ) | Negative | 15 Nov 2016 |